CAMO 2026 Highlights video HQ

CAMO 2026 | Cancer in Motion — Advancing Precision Oncology Actorius Innovations and Research, in collaboration with ACTREC, Navi Mumbai, successfully hosted CAMO 2026: From Circulating Tumor Cells to Dynamic Treatment Monitoring on 24 October 2026. The international scientific symposium brought together leading experts in liquid biopsy, oncology, and cancer research to explore emerging scientific advances and their potential to shape the future of precision oncology. We were honoured to welcome distinguished international speakers Prof. Catherine Alix-Panabières and Prof. Klaus Pantel, pioneers who jointly coined the term Liquid Biopsy in 2010. Their participation enriched scientific discussions on circulating tumor cells (CTCs), liquid biopsy, and dynamic treatment monitoring. The programme was led by Dr. T. Raja, Program Director, with Dr. Pankaj Chaturvedi, Director, ACTREC, as Chief Guest and Dr. J. N. Kulkarni as Chairperson. We also extend our sincere appreciation to Dr. Kumar Prabhash, Dr. K. Govind Babu, Dr. Bharat Bhosale, and all participating faculty members, organisers, and distinguished guests from across the oncology community. 🚀 A Key Highlight: Advancing Cancer Monitoring with OncoDiscover® A significant highlight of CAMO 2026 was Dr. Jayant Khandare’s presentation on OncoDiscover CTC, alongside the launch of two advanced testing solutions: 🔬 OncoDiscover® NGS A next-generation sequencing test designed to characterise the genomic landscape of cancer and support informed treatment decisions. 🧬 OncoDiscover® TDM A tumor-informed longitudinal monitoring test that integrates patient-specific tumor DNA alterations with circulating tumor cell (CTC) assessment to track cancer-related molecular changes over time. Together, these testing solutions mark an important step towards integrating genomic profiling with longitudinal molecular monitoring, enabling a more comprehensive understanding of cancer and its evolution over time. The scientific exchange, expert insights, and product launches at CAMO 2026 reinforced the importance of collaboration among researchers, clinicians, and innovators in advancing precision oncology. Our heartfelt thanks to ACTREC, our distinguished international speakers, faculty members, organisers, and all attendees for contributing to the success of CAMO 2026. Your participation and shared commitment continue to strengthen scientific collaboration and drive progress in cancer research and precision oncology. #CAMO2026 #Actorius #ACTREC #OncoDiscover #PrecisionOncology #LiquidBiopsy #CancerResearch #NGS #TumorMonitoring #CTC